These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8265206)

  • 1. Acquired resistance and persistence of Candida albicans following oral candidiasis in the mouse: a model of the carrier state in humans.
    Lacasse M; Fortier C; Chakir J; Côté L; Deslauriers N
    Oral Microbiol Immunol; 1993 Oct; 8(5):313-8. PubMed ID: 8265206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice.
    Chakir J; Côté L; Coulombe C; Deslauriers N
    Oral Microbiol Immunol; 1994 Apr; 9(2):88-94. PubMed ID: 7911989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of a corticosteroid destabilizes the host-parasite relationship in an experimental model of the oral carrier state of Candida albicans.
    Deslauriers N; Coulombe C; Carré B; Goulet JP
    FEMS Immunol Med Microbiol; 1995 Mar; 11(1):45-55. PubMed ID: 7599602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Saprophytic and parasitic Candida albicans: a pathogenetic problem in oral pathology].
    Valentini AF
    Minerva Stomatol; 1984; 33(4):571-88. PubMed ID: 6387431
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of
    Kirchner FR; Littringer K; Altmeier S; Tran VDT; Schönherr F; Lemberg C; Pagni M; Sanglard D; Joller N; LeibundGut-Landmann S
    Front Immunol; 2019; 10():330. PubMed ID: 30873177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental oral candidosis in the mouse: microbiologic and histologic aspects.
    Lacasse M; Fortier C; Trudel L; Collet AJ; Deslauriers N
    J Oral Pathol Med; 1990 Mar; 19(3):136-41. PubMed ID: 2187977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in acquired candidiasis of the palate.
    Budtz-Jörgensen E
    Scand J Dent Res; 1973; 81(5):372-82. PubMed ID: 4587166
    [No Abstract]   [Full Text] [Related]  

  • 8. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
    Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
    J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to C. albicans in monkeys with experimental candidiasis in the palate.
    Budtz-Jörgensen E
    Scand J Dent Res; 1973; 81(5):360-71. PubMed ID: 4202793
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1.
    de Repentigny L; Lewandowski D; Aumont F; Hanna Z; Jolicoeur P
    Methods Mol Biol; 2009; 470():359-68. PubMed ID: 19089395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed cellular hypersensitivity against C. albicans in patients wearing dentures].
    Ceballos A; Urquia M
    Rev Actual Odontoestomatol Esp; 1990; 50(390):47-50. PubMed ID: 2203391
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis.
    Yadev NP; Murdoch C; Saville SP; Thornhill MH
    Microb Pathog; 2011 Jun; 50(6):278-85. PubMed ID: 21296654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of yeastlike fungi of the genus Candida in the clinical picture of candidiasis of the oral mucosa].
    Volosevich LI; Sheremet ZA
    Vrach Delo; 1989 Oct; (10):114-6. PubMed ID: 2617968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic oral Candida albicans carriage in HIV-infection: frequency and predisposing factors.
    Fetter A; Partisani M; Koenig H; Kremer M; Lang JM
    J Oral Pathol Med; 1993 Feb; 22(2):57-9. PubMed ID: 8095300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis.
    Vultaggio A; Lombardelli L; Giudizi MG; Biagiotti R; Mazzinghi B; Scaletti C; Mazzetti M; Livi C; Leoncini F; Romagnani S; Maggi E; Piccinni MP
    Microbes Infect; 2008 Feb; 10(2):166-74. PubMed ID: 18249024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of oral candidiasis: host tissue damage and disseminated bacterial disease.
    Kong EF; Kucharíková S; Van Dijck P; Peters BM; Shirtliff ME; Jabra-Rizk MA
    Infect Immun; 2015 Feb; 83(2):604-13. PubMed ID: 25422264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental oral infection of mice with a pathogenic and a non-pathogenic strain of the yeast Candida albicans.
    Holbrook WP; Sofaer JA; Southam JC
    Arch Oral Biol; 1983; 28(12):1089-91. PubMed ID: 6365048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate Immunity and Saliva in Candida albicans-mediated Oral Diseases.
    Salvatori O; Puri S; Tati S; Edgerton M
    J Dent Res; 2016 Apr; 95(4):365-71. PubMed ID: 26747422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Candida: clearance, colonization, or candidiasis?
    Cannon RD; Holmes AR; Mason AB; Monk BC
    J Dent Res; 1995 May; 74(5):1152-61. PubMed ID: 7790592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.